CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法)

Multiplex Assay Kit for Cluster Of Differentiation 40 Ligand (CD40L) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD154; TRAP; HIGM1; IGM; IMD3; TBAM; T-BAM; TNFSF5; Gp39; TNF Superfamily Member 5; Hyper-IgM Syndrome; TNF-Related Activation Protein; T-Cell B-Cell Activating Molecule

(注:单次混测多因子不超过8个指标 )

  • CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法)产品包装(模拟)
  • CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法)产品包装(模拟)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。

样本回收率范围(%)平均回收率(%)
serum(n=5)79-9287
EDTA plasma(n=5)90-9894
heparin plasma(n=5)93-10599
sodium citrate plasma(n=5)80-9183

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%

线性

在定值血清及血浆样本内加入适量的CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法)含量的测定值与理论值的比率。

样本1:21:41:81:16
serum(n=5)93-102%85-99%97-105%88-99%
EDTA plasma(n=5)86-94%85-102%84-95%99-105%
heparin plasma(n=5)80-91%79-92%90-97%82-101%
sodium citrate plasma(n=5)88-97%80-90%89-104%89-99%

稳定性

经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本准备;
2. 加样(标准品、样本、磁珠)标准品或样本100μL及磁珠10μL,
    37°C酶标板振荡器孵育90分钟;
3. 磁吸甩干,加检测溶液A100μL,37°C酶标板振荡器孵育60分钟;
4. 磁吸洗板3次;
5. 加检测溶液B100μL,37°C振动孵育30分钟;
6. 磁吸洗板3次;
7. 加鞘液100μL,旋涡震荡2分钟后读数。

实验原理

将CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法)抗体包被于磁珠,制成固相载体,向微孔中分别加入标准品或标本以及磁珠,其中的CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法)与连接于固相载体上的抗体结合,然后加入生物素化的CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法)抗体,将未结合的生物素化抗体洗净后,加入PE标记的亲和素,再次彻底洗涤后即可上机读数。MFI值和样品中的CD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法)呈正相关。

赠品

相关产品

编号适用物种:Homo sapiens (Human,人)应用(仅供研究使用,不用于临床诊断!)
RPA119Hu02CD40配体(CD40L)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA119Hu04CD40配体(CD40L)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA119Hu01CD40配体(CD40L)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA119Hu03CD40配体(CD40L)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA119Hu02CD40配体(CD40L)多克隆抗体WB; IHC; ICC; IP.
PAA119Hu03CD40配体(CD40L)多克隆抗体WB; IHC; ICC; IP.
PAA119Hu01CD40配体(CD40L)多克隆抗体WB; IHC; ICC; IP.
LAA119Hu71CD40配体(CD40L)多克隆抗体(生物素标记)WB; IHC; ICC.
LAA119Hu81CD40配体(CD40L)多克隆抗体(异硫氰酸荧光素标记)WB; IHC; ICC; IF.
MAA119Hu21CD40配体(CD40L)单克隆抗体WB; IHC; ICC; IP.
MAA119Hu23CD40配体(CD40L)单克隆抗体WB; IHC; ICC; IP.
MAA119Hu22CD40配体(CD40L)单克隆抗体WB; IHC; ICC; IP.
MAA119Hu25CD40配体(CD40L)单克隆抗体WB; IHC; ICC; IP.
MAA119Hu24CD40配体(CD40L)单克隆抗体WB; IHC; ICC; IP.
RAA119Hu21CD40配体(CD40L)重组抗体WB; IF; ICC; IHC; IP; FCM.
RAA119Hu22CD40配体(CD40L)重组抗体WB; IF; ICC; IHC; IP; FCM.
SEA119HuCD40配体(CD40L)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA119HuCD40配体(CD40L)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
Basic Research in CardiologySecretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation[PubMed: 22899170]
MoleculesThe Protective Effects of Alisol A 24-Acetate from Alisma canaliculatum on Ovariectomy Induced Bone Loss in Vivo[Pubmed:26760992]
Journal of Neuroinflammation Th17-skewed immune response and cluster of differentiation 40 ligand expression in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis.[pubmed:28114998]
BMC NephrologyRenal effects of metallothionein induction by zinc in vitro and in vivo[pubmed:28302075]
Toxicology and Applied Pharmacology Effects of diisononyl phthalate on osteopenia in intact mice [pubmed:28893586]
INTERNATIONAL JOURNAL OF CARDIOLOGYShort and long-term changes in platelet and inflammatory biomarkers after cryoballoon and radiofrequency ablation[Pubmed: 30857843]
Available at SSRN 3335365 Evaluating the Platelet Activation Related to the Degradation of Biomaterials by Scheme of Molecular Markers[]
Data in BriefData for short and long-term prothrombotic biomarkers after cryoballoon and radiofrequency ablation[]
journal of thoracic and cardiovascular surgeryEvaluating Platelet Activation Related to the Degradation of Biomaterials Using Molecular Markers[Pubmed: 32812629]
Thrombosis ResearchFeasibility study of use of rabbit blood to evaluate platelet activation by medical devices[Pubmed: 31838449]
CancersPredictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study[Pubmed: 32085544]
Persistently higher serum sCD40L levels are associated with mortality in septic patients[]
Journal of Orthopaedic TranslationTyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-¦ÊB and MAPK activation[33981577]
Bioactive MaterialsSecretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy[34820587]